SlideShare ist ein Scribd-Unternehmen logo
1 von 35
Downloaden Sie, um offline zu lesen
Celanese Corporation
    May 2008
1
Forward looking statements;
    Reconciliation and use of non-GAAP
    measures to U.S. GAAP
    This presentation may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues
    or performance, capital expenditures, financing needs and other information that is not historical information. When used in this presentation, the words “outlook,”
    “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify
    forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance
    that the company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to
    differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause
    actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the company’s filings with the
    Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to
    update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated
    events or circumstances.

    This presentation reflects three performance measures, operating EBITDA, adjusted earnings per share and adjusted free cash flow as non-U.S. GAAP measures.
    The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for operating EBITDA is operating
    profit; for adjusted earnings per share is earnings per common share-diluted; and for adjusted free cash flow is cash flow from operations.

    ►Operating EBITDA, a measure used by management to measure performance, is defined as operating profit from continuing operations, plus equity in net earnings
    from affiliates, other income and depreciation and amortization, and further adjusted for other charges and adjustments. We provide guidance on operating EBITDA
    and are unable to reconcile forecasted operating EBITDA to a GAAP financial measure because a forecast of other charges and other adjustments is not practical.
    Our management believes operating EBITDA is useful to investors because it is one of the primary measures our management uses for its planning and budgeting
    processes and to monitor and evaluate financial and operating results. Operating EBITDA is not a recognized term under U.S. GAAP and does not purport to be an
    alternative to operating profit as a measure of operating performance or to cash flow from operations as a measure of liquidity. Because not all companies use
    identical calculations, this presentation of operating EBITDA may not be comparable to other similarly titled measures of other companies. Additionally, operating
    EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not consider certain cash requirements such as interest
    payments, tax payments and debt service requirements nor does it represent the amount used in our debt covenants.

    ►Adjusted earnings per share is a measure used by management to measure performance. It is defined as net earnings (loss) available to common shareholders plus
    preferred dividends, adjusted for other charges and adjustments, and divided by the number of basic common shares, diluted preferred shares, and options valued
    using the treasury method. We provide guidance on an adjusted earnings per share basis and are unable to reconcile forecasted adjusted earnings per share to a
    GAAP financial measure because a forecast of other charges and other adjustments is not practical. We believe that the presentation of this non-U.S. GAAP measure
    provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations,
    and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided with a more meaningful understanding of our
    ongoing operating performance. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.

    ►The tax rate used for adjusted earnings per share is the tax rate based on our original guidance communicated at the company’s investor day in December 2007.
    We adjust this tax rate during the year only if there is a substantial change in our underlying operations; an updated forecast would not necessarily result in a change
    to our tax rate used for adjusted earnings per share. The adjusted tax rate may differ significantly from the tax rate used for U.S. GAAP reporting in any given
    reporting period. It is not practical to reconcile our prospective adjusted tax rate to the actual U.S. GAAP tax rate in any future period.

    ►Adjusted free cash flow is defined as cash flow from operations less capital expenditures, other productive asset purchases, operating cash from discontinued
    operations and certain other charges. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors
    regarding changes to the company’s cash flow. Our management and credit analysts use adjusted free cash flow to evaluate the company’s liquidity and assess credit
    quality. This non-U.S. GAAP measure is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.
2
Who is Celanese?



                                                      Superior Value Creation
                                 Strategy
                                                          Industry Leader
                          Clear focus on growth and   ►
                                value creation
                                                              Geographically balanced
                                                          ●
                                                              global positions
         Culture                                              Diversified end market
                             Leading Global               ●
     Strong performance                                       exposure
                          Integrated Producer
        built on shared     of Chemicals and
                                                          Strong Cash Generation
                                                      ►
        principles and
                          Advanced Materials
          objectives
                                                          Significant Growth
                                                      ►
                                                          Capability
                                Execution                     Track record of execution
                                                          ●
                          Demonstrated track record
                                                              Clearly defined
                                                          ●
                            of delivering results
                                                              opportunities



3
Globally balanced and integrated
    businesses aligned to accelerate growth

                     Differentiated Intermediates      Specialty Products
    Building Block


                                                       Acetate
                                                                        Consumer
                                                                        Specialties
                                        Anhydride
                                                                           (CS)
                                                      Nutrinova
                                        and esters

                         Acetic
                          Acid
                                                     Emulsions
                                                                         Industrial
      Raw                                 VAM          PVOH             Specialties
     Materials
                                                                            (IS)
                                                     AT Plastics
                                  Formaldehyde


                                                       Ticona
                                                                         Advanced
                                                     Engineering
                         Acetyl Intermediates                           Engineered
                                                      Polymers
                                  (AI)                                   Materials
                                                                          (AEM)
                                                      Affiliates


4
Today’s portfolio: higher growth, more
    specialty

                                                                                                                2007 Financial Highlights:
                                                                                                          ►
                                            Operating EBITDA1
                                                                                                                     Net sales - $6,444 million
                                                                                                                ●
                                                                                                                     Operating EBITDA - $1,325 million
                                      Advanced Engineered Materials                                             ●
                                      Consumer and Industrial Specialties
                                                                                                                Strategic growth plans
                                                                                                          ►
                                      Acetyl Intermediates
                      1,400
                                                                                                                continue to accelerate
                                                                                                                earnings of specialty
                      1,200
                                                                                                                businesses
                      1,000
                                                                                                                     Essentially all growth has come from
                                                                                                                ●
      $ in millions




                                                                                                                     specialty businesses
                       800
                                                                                                                     Two-thirds of 2010 Growth
                                                                                                                ●
                                                                                                                     Objectives expected from specialty
                       600
                                                                                                                     businesses
                                                                                                                Resulting in:
                       400                                                                                ►
                                                                                                                     Higher growth rates
                                                                                                                ●
                       200
                                                                                                                     Increased overall earnings power of
                                                                                                                ●
                                                                                                                     the portfolio
                          -
                                                                                                                     Reduced volatility
                                                                                                                ●
                                 2005                       2006                       2007


    1Operating            EBITDA excludes Other Activities of ($122), ($134) and ($82) respectively for the periods presented
5
Committed to delivering value creation

                                                         Primary Growth Focus

                                                                                             Balance   Operational    EBITDA
                           Group              Asia   Revitalization   Innovation   Organic
                                                                                              Sheet    Excellence     Impact

                           Consumer and
    EPS Operating EBITDA




                           Industrial          X          X              X                                 X         >$100MM
                           Specialties
                           Advanced
                           Engineered          X                         X           X                     X         >$100MM
                           Materials
                           Acetyl
                                               X                                     X                     X         >$100MM
                           Intermediates
                           Celanese                                                                                  Incremental
                                                                                               X           X
                           Corporate                                                                                     EPS




                                           $350 – $400 million increased EBITDA profile
                                                    plus EPS potential by 2010

6
On track and clear path forward to
    accelerate 2010 Growth Objectives


                    Operating EBITDA Growth Objectives

                                 Advanced Engineered Materials
                    400
                                                                            AEM: volume growth > 2X GDP
                                 Consumer and Industrial Specialties    ►
                                 Acetyl Intermediates
                                                                            through further penetration
                                                                            CIS: Acetate continues
                                                                        ►
    $ in millions




                                                                            execution on revitalization
                    200
                                                                            strategy; Emulsions/PVOH
                                                                            revitalization commences
                                                                            AI: Nanjing acetic acid plant
                                                                        ►
                                                                            startup leads integrated complex
                     0
                          2007          2008        2009         2010




7
Asia strategy: high-return growth


           Celanese Nanjing Integrated Complex                Investment Dynamics

                  GUR®       Celstran®                      Total investment: $300 -
                                                        ►
    Warehouse                                  Flare
                   Unit        Unit                         $350 million – over 80%
                                                            complete
      Acetic Anhydride               Vinyl Acetate
                                                            Total revenue: $600 - $800
                                                        ►
            Unit                     Monomer Unit
                                                            million when sold out by
                                                            2010
                                                            Incremental EBITDA: $120 -
                                                        ►
                                          Acetic Acid
                       Utilities /
                                                            $150 million by 2010
                                             Unit
                      Tank Farm
     Emulsions
      Complex

                  Administration &
                                                                ROIC = 25 – 30%
                                   Compounding
                   Maintenance



8
AEM: value in technology and performance
    realized in price and positioned for growth

    $100 / kg                                         Price for Performance
     $10 / kg
      $3 / kg
      $100/kg
                                                                                  High-Performance Polymers (HPP)
                                                                           5%
       $10/kg
                                                                                  Engineering Thermoplastics (ETP)
        $3/kg



                                                           others = 2%
                        Performance
          Price Range



                                      Ranges




                                                            PU = 6%
                                                                                      95% Standard Polymers
      $1/ kg                                                PET = 7%

                                                     ABS, SAN, ASA: 3%

                                                                   PS, EPS = 8%
                                               PVC = 17%

                                               PE = 31%                PP = 21%
        $1/kg
                                                            Range of Products



9
AEM: significant opportunity for
     increased penetration in high growth
     region
                                                                                 Advanced Engineered Materials
                       Global Auto Production
                                                                                        Type of Resins
          China

         Japan
                                                                                            6
                                                                            2001
            U.S.

      Germany
                                                                                                      14
                                                                            2007
           India

       S. Korea
                                                                           2010E                           18
                                   China production
         France
                                    nearly doubles                        Highest
          Brazil
                                    within 5 years                                                                   40
                                                                          Current
          Spain                                                            Model
        Canada                    2006 Production                          China
                                                                                         2.5 Trend
                                                                          Current
                                  Production Growth 2006-2012
        Mexico

                   0      3,000    6,000     9,000    12,000    15,000
                                                                                                Pounds per Vehicle
                        Vehicle Production (Thousand units)

     Source: Global Insight                                              Source: Celanese Estimates



10
AEM: megatrends driving growth for
     Vectra® LCP through LED lighting
                                                                         Customer
                                                                       Requirements
                                                                      High flow
                                                                  ►
                                                                      Low emissions
                                                                  ►
                                                                      Dimensional
                                                                  ►
                                                                      stability
                                                                      Pinpoint light
                                                                  ►
                                 Drivers:
                                                                      source
                                     Improved safety
                                 ►
                                     Lower energy consumption
                                 ►
          $5.1 billion                                                $17.4 billion
                                     Miniaturization
                                 ►
                                     Aesthetics
                                 ►
            in 2006                                                     in 2017
                                     Design trends
                                 ►




             Audi A8         Audi R8           LED Street Lamps   Applying Connector
         Daytime Running   54 LEDs per                             Expertise to New
              Lights        Headlamp                                Technologies

11   Source: Philips
IS: technology enhancements open
     $1.0 billion of new growth opportunities


                            Global Vinyl Emulsions                  Applications Driving 2010 Growth

                                                                                       2010E
                                                                                                   Growth
                      4.0
                                                                   Applications      Application
                                                       >25%                                         Rate
                                                                                     Sales ($MM)
                                         ~30%
                      3.0
      $ in billions




                            ~25%                               Low VOC and nano
                                                                                     $400 – $500    10+%
                                      increase in              paints
                      2.0
                                      vinyl space
                                                               Engineered
                                                                                     $200 – $300   3% - 5%
                                                               fabrics/glass fiber
                      1.0
                                                               Enviro-friendly
                                                                                     $100 – $200     8%
                                                               adhesives
                      0.0
                            2006                       2010E   China building/
                                                                                     $100 – $200    30+%
                                                               construction
                                              Others
                                   Celanese




                               $1.0 billion expansion = >$250 million in revenue

12
IS: current regulatory trends enabling
     growth potential for VAE in U.S.
                                                                                                                             VOC Regulatory Trends for
                               European Interior Paint
                                                                                European VAE Success                          Flat to Semi-Gloss Paints
                               Industry Development

                                                            50%




                                                            VAE Share of Interior
                                                                                                                                                1999




                                                                                                                    US VOC grams/liter
          EU VOC parts/liter




                                                                                                                                                VOC (g/L): 250 – 380




                                                                  Paints
                                       VOC Content                                                                                                     2004
                                                                                                                                                       VOC (g/L): 100 – 150


                                                               0%
                                                                                                                                           European
                                                                                    1996         2006       2010E
                                                                                                                                           Standard
                                                                                      Celanese          Others
                               1990                  2006
                                                                                                                                         1999                          2008



       Current trends in U.S. following European precedent
     ►
     ► In 2008, Southern California will further restrict emission requirements in paints
     ► Today, less than 25% of the interior paints meet the contemplated guidelines
            $100 - $2001 per ton estimated cost for non-VAE emulsions to achieve standard
     ► U.S. interior paint opportunity ~$1.0 billion


                                VAE provides favorable substitution for low-VOC requirements
     1   Based on Celanese estimates
13
AI: consumer trends support long-term
     growth 1-2% greater than GDP

                                                              Acetyl Product
        Key Trends      End Market Increased Demand
                                                                Benefited
                     Paints, coatings, inks and adhesives
     Emerging
                                                            VAM, Esters
                     used in residential and commercial
     Economies
                     applications
                                                            Acetic Acid, Acetic
     Demographics    Pharmaceuticals
                                                            Anhydride
                     Increased demand for packaging films
     Affluence                                              VAM
                     (PVOH, EVOH)

     Convenience     Films and polyester                    Acetic Acid, VAM

     Water           Consumption of bottled water           Acetic Acid

                     Environmentally friendly paints and
     Environment                                            VAM (for VAE)
                     coatings

14
AI: continued >GDP demand growth
      driven by each major end use

                                                                  Acetic Acid End-Use Growth
                                                                                                                                                                         Annual acetic acid
                                                                                                                                                                       ►
                                                                          (2000 – 2010)
                                                                                                                                                                         demand growth of ~4.5%
                                                                                                                                                                         through at least 2010
                                               12,000                                                              350
                                                                                                                                                                       ► Each end market is




                                                                                                                           China Acetic Acid Demand (indexed at 100)
                                                                                                                                                                         experiencing favorable
                                                                               CAGR 12%
          Acetic Acid Demand by End-Use, kta




                                                                                                                   300
                                               10,000
                                                                                                                                                                         demand expansion
                                                                                                                                                                       ► 2007 – 2010 estimated
                                                                                                                   250
                                                8,000
                                                                                                                                                                         CAGR:
                                                                                                                   200
                                                                                                                                                                           VAM:            6%
                                                6,000
                                                                                                                   150
                                                                                                                                                                           PTA:            7%
                                                4,000
                                                                                                                                                                           Esters:         4%
                                                                                                                   100

                                                                                                                                                                           Anhydride:      3%
                                                2,000
                                                                                                                   50


                                                   0                                                               0
                                                          2000           2004             2007           2010

                                                                                                                                                                          Strong acetic acid
                                                    VAM     PTA       Esters      Anhydride      Other      China Demand
                                                                                                                                                                        continues through 2010

     Source: Tecnon and Celanese Estimates, 2008
15
AI: advantaged operating costs and
     favorable supply/demand continues
     through 2010

                  2010E Acetic Acid Cost Curve (kt)
                                                                                         Acetic Acid Supply/Demand Balance
                   (based on nameplate capacity)

                                                                                                        High Cost
                                                                                     12,000
                                                     Ethylene                                           Low Cost
                               High Cost Supply
                                                                                                        Demand
                                                   Ethanol                           10,000


                                                                                         8,000
                          Celanese
                                             Conventional
                         Technology




                                                                                    kt
                                                                                         6,000
                                              MeOH/CO

                   AOPlus™/Leading                                                       4,000
                     Competition
                                                                                         2,000
          By-
          prod
                                                                                          0
                                                                                                 2004       2005    2006   2007   2008E   2009E   2010E
                                                                              Utilization of
      0          2,000    4,000   6,000   8,000   10,000 12,000 14,000        Effective
                                                                              Capacity1(11/07 ): 91%        93%     92%    94%     93%     91%      91%




     12008E-2010E  effective utilization based on external analysis assumptions
     Source: Celanese estimates, available public data
16
Recent initiatives to support growth
     beyond 2010
                                                 Recent Actions
                                      Direct to China
                                  ►
                                         Announced plans to add polymer compounding
                                         unit to the Nanjing Complex
           Advanced
                                         Commissioned start-up of Nanjing Celstran® unit
          Engineered
           Materials                  Kelsterbach relocation
                                  ►
                                         Announced 40% capacity expansion at new
                                         European POM facility

                                      Signed an agreement with Wison to double
                                  ►
                                      Nanjing CO supply increasing reliability and
                                      supporting future expansion
             Acetyl
                                      Announced agreement with SWRI, a leading
         Intermediates            ►
                                      Chinese technology institute, to acquire
                                      technology licensing rights and development
                                      capabilities



     Recently announced authorization for $400 million share repurchase
17
Strong cash flow generation enables
     future earnings growth
                                    Adjusted Free Cash Flow1

                                                                                            Strong operating results
                                                                                      ►
                                                                        550 - 600
                                     456
                                                                                            Working capital productivity
                                                                                      ►
                                                          385
                  $ in millions




                                                                                            Decrease in overall borrowing
                                                                                      ►
                                                                                            costs since 2005
                                                                                            Continued improvement in
                                                                                      ►
                                                                                            interest coverage ratio
                                     2006                 2007            2008E



                                                                                            Enhanced capital flexibility
                                                                                      ►
                                  Operating EBITDA/Net Interest
                                                                                            Bias for growth spending
                                                                                      ►
             7x
                                    8.0% Borrowing Rate
                                                                              6.5x
             6x

                                                                                            Maximize return to
                                                                                      ►
                                                                 6.1x

             5x

                                                                                            shareholders
                                                4.5x
             4x
                                   3.9x
             3x


             2x
                                                                              6.9%

             1x


             0x
                                   2005         2006             2007        2008E


     1 Adjustedfree cash flow calculated as cash flow from operations less capital expenditures less other productive asset purchases less operating
18
      cash from discontinued operations plus certain other charges – 2008 estimate excludes Kelsterbach relocation
Growth focused cash flow and capital
     structure strategy

                                   Cash Available for Strategic Use



                Execute Growth Strategy                                 Optimize Capital Structure


     Cost Reduction
                                              Core/Bolt-on         Share                            Debt
     & Revitalization     Growth Projects                                         Dividends
                                              Acquisitions       Repurchase                       Repayment
        Projects



                                                                         Capital Structure Objectives
                        Investment Criteria
                                                                 Cost
         Aligned with Strategic Pillars                      ►
     ►
                                                                 Stability
         2 – 4 year simple payback period                    ►
     ►
                                                                 Flexibility
         > 20 – 50% ROIC                                     ►
     ►
                                                                 Maximize shareholder value
                                                             ►




19
Case for improved valuation
                                                                       3Yr Avg EBITDA/Sales2

                    3Yr Avg FCF Yield2                                                                                     3Yr Avg EBITDA Growth2
                                                                                            20%      20%
                                                                                    18%
                                                                       15%
                                               7%
                                                               14%           14%
                                                                                                                                                     14%
                                                                                                                                                           13%
         5%                                                                                                                10%
                                        5%
                                 4%
                         4%
                  4%
                                                                                                                                           2%




                                                               DOW     PPG   EMN    ROH     FMC          CE                          -4%
                                                                                                                     -7%
                                                                                                                     DOW   PPG      EMN    ROH    FMC      CE
        DOW       PPG    EMN    ROH    FMC     CE

                                                                     NorthAvgEBITDAYield2 1 21
                                                                           America Sales1
                                                                     3Yr3YrForward % of Sales
                                                                      3YrAvg % FCF Growth
                                                                          Asia EBITDA/Sales
                                                                            Avg of P/E2
                                                                     66%                                      28%
                                                                                                  12%         7%
                                                                                                  20%         10%
                                                                                                  15.8        20%
                                                                             53%     52%
                                                                      8%             18%
                                                                                     13.9
                                                                             13.4    20%
                                                        45%
                                                         5%                                       45%
                                                                                                  5%
                                                                     15%
                                                        11.6                                                  11.4
                                                                     11.3
                                                        14%                  14%      4%
                                                                              4%      3%          15%
                                                                      4%     14%
                                                         12%                                                  28%
                                                                      9%

                                                                             -4%
                                                         -6%
                North America % of Sales1
                                                                                                                                  Asia % of Sales1
                                                        DOW          PPG     EMN     ROH          FMC          CE
                         59%                                                                                                                               28%
                  57%
                                                                                                                     25%
                                49%
                                                                                                                                            22%
        38%                             37%
                                                                                                                                     16%
                                               29%
                                                                                                                                                     13%
                                                                                                                            11%




        DOW       PPG    EMN    ROH    FMC     CE
                                                                                                                     DOW    PPG      EMN   ROH       FMC    CE

     1Based   on information provided in 2007 Form 10-K filings
     2Thompson     Financial as of April 30, 2008, Company reports, Celanese estimates
20
Appendix




21
Delays continue to be common for
     acetyl projects
     Company                       Capacity       2005                 2006                      2007         2008             2009                         2010
                                     300kt
     BP/FPC                                                           SU
                                              A              X

                                     150kt
     BP / Yaraco                              A     X SU

                                     200kt
     Wujing                                   A                            X                      X     SU

                                     150kt
     Sopo                                     A          X        SU

                                     150kt
     Fanavaran                                A              X             SU

                                     200kt
     Lunan Cathay                                            X   SU
                                              A

                                     500kt                                      Cancelled
     Acetex (Tasnee)                                                       A


                                     600kt
     Celanese Nanjing (Phase 1)                                                                  X SU
                                                                                     A       X


                                     550kt
     BP / Sinopec                                                                        A               X           X     X

                                     425kt
     Sipchem                                                                                             A           X         X       X


                                     200kt
     Daqing                                                                      A                X      SU


                                     200kt
     Hualu Hensheng                                                                                                                             X
                                                                                                                                               A

                                     350kt
     Lunan Cathay (expansion)                                                                                              A           X


                                     600kt
     Sopo (expansion)                                                                                                              A                X


                                     200kt
     Tianjin Bohei                                                                                                                         A            X


                        Company announced startup            CE 2005 update                       CE 2006 update         CE 2007 update
                  A


                                     X = Project delay                                   SU = Actual plant startup
22
2008 business outlook
     (updated on April 22, 2008)

                       Volume growth >2x GDP across both transportation
                     ►
                       and non-transportation applications
     Advanced
                     ► Continued high energy and raw material costs
     Engineered
                       expected to pressure margins
                                                                    2008 Guidance:
     Materials
                     ► Significant progress expected in Nanjing
                       production capabilities                       Adjusted EPS
                                                                          $3.60 to $3.85
                       Synergy capture from APL integration
                     ►
     Consumer
                     ► Strong underlying business fundamentals
     Specialties
                                                                        Operating EBITDA
                       High raw material costs continue
                     ►
     Industrial                                                       $1,355 to $1,415 million
                     ► Realize benefits from revitalization efforts
     Specialties
                                                                         Forecasted 2008
                       Continued strong global demand
                     ►
                                                                     adjusted tax rate of
                     ► Incremental acetic acid volume
                                                                            26%
                       associated with China expansion
     Acetyl
                     ► VAM and acetic anhydride production scheduled to
     Intermediates
                       begin in Nanjing
                     ► Prices expected to adjust only modestly in 2008



23
Advanced Engineered Materials

          in millions                     1st Qtr 2008    1st Qtr 2007
          Net Sales                                              $262
                                          $294 up 12%
          Operating EBITDA                                         $67
                                         $60 down 10%


     First Quarter 2008:
     ► Net sales increase driven by volume growth (6%) and positive
        currency effects (8%)
     ► Growth in China continues to drive results
     ► Slight pricing declines due to geographic and product mix
     ► Higher raw material and energy costs continue to pressure margins
     ► Overall lower earnings from equity affiliates contributed to decrease
        in Operating EBITDA


24
Consumer Specialties

         in millions                   1st Qtr 2008   1st Qtr 2007
         Net Sales                                            $269
                                        $282 up 5%
         Operating EBITDA                                      $60
                                         $65 up 8%


     First Quarter 2008:
     ► Net sales increase primarily driven by European acquisition,
        improved pricing on global demand and favorable currency impacts
     ► Pricing more than offset significantly higher energy costs
     ► Operating EBITDA improvement also includes acquisition synergies




25
Industrial Specialties

          in millions                  1st Qtr 2008   1st Qtr 2007
          Net Sales                                           $346
                                        $365 up 5%
          Operating EBITDA                                     $26
                                        $36 up 38%


     First Quarter 2008:
     ► Increase in net sales primarily driven by favorable pricing and foreign
        currency effects
     ► Volumes pressured by continued softness in U.S. housing and
        construction segments
     ► Increased revenues offset raw material cost pressures




26
Acetyl Intermediates

                                       1st Qtr 2008   1st Qtr 2007
         in millions
         Net Sales                                            $839
                                      $1,096 up 31%
         Operating EBITDA                                     $174
                                       $246 up 41%


     First Quarter 2008:
     ► Strong global demand sustained higher pricing levels and drove
        record sales for the quarter
     ► Incremental volumes from the Nanjing plant also contributed to
        increase
     ► Favorable supply/demand environment and increased dividends
        from Ibn Sina more than offset higher raw material and energy
        costs



27
Reg G: Reconciliation of Adjusted EPS
                  Adjusted Earnings Per Share - Reconciliation of a Non-U.S. GAAP Measure

                                                                                                                  Three Months Ended
                                                                                                                       March 31,
                                                                                                                   2008        2007
             (in $ millions, except per share data)
             Earnings from continuing operations
                                                                                                                                              171
               before tax and minority interests                                                                         218
             Non-GAAP Adjustments:
                                                    1
               Other charges and other adjustments                                                                                             18
                                                                                                                          22
                                                                                                                                               (2)
               Refinancing costs                                                                                           -
             Adjusted earnings from continuing operations
                                                                                                                                              187
               before tax and minority interests                                                                         240
                                                       2
             Income tax provision on adjusted earnings                                                                                        (52)
                                                                                                                         (62)
                                                                                                                                                 -
             Minority interests                                                                                            -
             Adjusted earnings from continuing operations                                                                178                  135
             Preferred dividends                                                                                                               (2)
                                                                                                                          (3)
             Adjusted net earnings available to common shareholders                                                      175                  133
             Add back: Preferred dividends                                                                                                      2
                                                                                                                           3
             Adjusted net earnings for adjusted EPS                                                                      178                  135



             Diluted shares (millions)
             Weighted average shares outstanding                                                                                         159.3
                                                                                                                      152.0
             Assumed conversion of Preferred Shares                                                                                       12.0
                                                                                                                       12.0
             Assumed conversion of Restricted Stock                                                                                          -
                                                                                                                        0.5
                                                                                                                                           3.1
             Assumed conversion of stock options                                                                        2.8
             Total diluted shares                                                                                                        174.4
                                                                                                                      167.3
             Adjusted EPS                                                                                        $     1.06        $      0.77
             1
                 See Table 7 for details
             2
                 The adjusted tax rate for the three months ended March 31, 2008 is 26% based on the forecasted adjusted tax rate for 2008.




28
Reg G: Other Charges and Other
     Adjustments
                                              Other Charges and Other Adjustments
       Other Charges:
                                                                                         Three Months Ended
                                                                                              March 31,
       (in $ millions)                                                                   2008          2007
       Employee termination benefits                                                                          -
                                                                                               7
       Plant/office closures                                                                                  -
                                                                                               7
       Ticona Kelsterbach plant relocation                                                                    -
                                                                                               2
                                                                                                              1
       Other                                                                                   -
          Total                                                                               16              1



       Other Adjustments: 1
                                                                                         Three Months Ended                      Income
                                                                                              March 31,                         Statement
                                                                                                                             Classification
       (in $ millions)                                                                   2008          2007
       Ethylene pipeline exit costs                                                                         10    Other income/expense, net
                                                                                                -
       Business optimization                                                                                 2    SG&A
                                                                                               9
       Ticona Kelsterbach plant relocation                                                                   -    Cost of Sales
                                                                                              (2)
       Other                                                                                                 5    Various
                                                                                              (1)
                                                                                               6            17
          Total

                                                                                             22            18
       Total other charges and other adjustments
       1
           These items are included in net earnings but not included in other charges.




29
Reg G: Other Charges and Other
     Adjustments
                                         Other Charges and Other Adjustments
         Other Charges:
                                                                                   Three Months Ended               Twelve Months Ended
                                                                                      December 31,                     December 31,
         (in $ millions)                                                           2007         2006                 2007          2006
         Employee termination benefits                                                                 1                                12
                                                                                         5                                  32
                                                                                                                                        (1)
         Plant/office closures                                                                        (1)                   11
                                                                                         7
         Insurance recoveries associated with plumbing cases                                          (2)                               (5)
                                                                                        (2)                                 (4)
         Insurance recoveries associated with Clear Lake, Texas                                        -                                 -
                                                                                       (40)                                (40)
         Resolution of commercial disputes with a vendor                                               -                                 -
                                                                                       (31)                                (31)
         Deferred compensation triggered by Exit Event                                                 -                                 -
                                                                                         -                                  74
         Asset impairments                                                                             -                                 -
                                                                                         -                                   9
         Ticona Kelsterbach plant relocation                                                           -                                 -
                                                                                         1                                   5
                                                                                                       -
         Other                                                                                                                           4
                                                                                         -                                   2
            Total                                                                      (60)           (2)                   58          10



         Other Adjustments: 1
                                                                                   Three Months Ended               Twelve Months Ended
                                                                                      December 31,                     December 31,
         (in $ millions)                                                           2007         2006                 2007          2006
         Executive severance & other costs related
            to Squeeze-Out                                                                                   2                               30
                                                                                            -                                  -
         Ethylene pipeline exit costs                                                                        -                                -
                                                                                            -                                 10
         Business optimization                                                                               8                               12
                                                                                           8                                  18
         Foreign exchange loss related to refinancing transaction                                            -                                -
                                                                                            -                                 22
         Loss on AT Plastics films sale                                                                      -                                -
                                                                                            -                                  7
                                                 2
         Discontinued methanol production                                                                   16                               52
                                                                                           -                                  31
         Gain on disposal of investment (Pemeas)                                                           (11)                             (11)
                                                                                           -                                   -
         Gain on Edmonton sale                                                                               -                                -
                                                                                         (34)                                (34)
         Other                                                                                               2                               (1)
                                                                                          (7)                                  1
                                                                                         (33)               17                55             82
           Total

                                                                                         (93)               15              113              92
         Total other charges and other adjustments
         1
             These items are included in net earnings but not included in other charges.
         2
             Adjusted earnings per share included earnings from its discontinued methanol production which was included in the company's 2007 guidance.
30
31
     Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA -
      a Non-U.S. GAAP Measure

                                                                                   Three Months Ended
                                                                                        March 31,
     (in $ millions)                                                                2008          2007
     Net Sales
                                                                                          294
      Advanced Engineered Materials                                                                         262
                                                                                          282
      Consumer Specialties                                                                                  269
                                                                                          365
      Industrial Specialties                                                                                346
                                                                                                                                          EBITDA

                                                                                        1,096
      Acetyl Intermediates                                                                                  839
                       1
      Other Activities                                                                      -                 1
                                                                                         (191)
      Intersegment eliminations                                                                            (162)
     Total                                                                              1,846             1,555

     Operating Profit (Loss)
                                                                                           30
      Advanced Engineered Materials                                                                          36
                                                                                           50
      Consumer Specialties                                                                                   48
                                                                                           17
      Industrial Specialties                                                                                 12
                                                                                          177
      Acetyl Intermediates                                                                                  132
                       1
      Other Activities                                                                    (40)              (22)
     Total                                                                                234               206


     Equity Earnings and Other Income/(Expense) 2
                                                                                            9
      Advanced Engineered Materials                                                                          14
                                                                                            -
      Consumer Specialties                                                                                    -
                                                                                            -
      Industrial Specialties                                                                                  -
                                                                                           29
      Acetyl Intermediates                                                                                    5
                       1
      Other Activities                                                                      4                 4
     Total                                                                                 42                23


     Other Charges and Other Adjustments 3
                                                                                            1
      Advanced Engineered Materials                                                                           -
                                                                                            1
      Consumer Specialties                                                                                    1
                                                                                            5
      Industrial Specialties                                                                                  -
                                                                                            8
      Acetyl Intermediates                                                                                   13
                       1
      Other Activities                                                                      7                 4
     Total                                                                                 22                18

     Depreciation and Amortization Expense
                                                                                                                                          Reg G: Reconciliation of Operating




                                                                                           20
      Advanced Engineered Materials                                                                          17
                                                                                           14
      Consumer Specialties                                                                                   11
                                                                                           14
      Industrial Specialties                                                                                 14
                                                                                           32
      Acetyl Intermediates                                                                                   24
                       1
      Other Activities                                                                                        2
                                                                                            3
     Total                                                                                 83                68

     Operating EBITDA
                                                                                           60
      Advanced Engineered Materials                                                                          67
                                                                                           65
      Consumer Specialties                                                                                   60
                                                                                           36
      Industrial Specialties                                                                                 26
                                                                                          246
      Acetyl Intermediates                                                                                  174
                       1
      Other Activities                                                                    (26)              (12)
     Total                                                                                381               315
     1
         Other Activities primarily includes corporate selling, general and administrative expenses and the results from captive insurance companies.
     2
         Includes equity earnings from affiliates, dividends from cost investments and other income/(expense).
     3
         Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations (See Table 7).
32
 Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA -
  a Non-U.S. GAAP Measure

                                                                               Three Months Ended                 Twelve Months Ended
                                                                                  December 31,                       December 31,
 (in $ millions)                                                                2007        2006                   2007         2006
 Net Sales
                                                                                      253                              1,030
  Advanced Engineered Materials                                                                         224                                915
                                                                                      279                              1,111
  Consumer Specialties                                                                                  224                                876
                                                                                                                                                     EBITDA

                                                                                      331                              1,346
  Industrial Specialties                                                                                309                              1,281
                                                                                    1,083                              3,615
  Acetyl Intermediates                                                                                  831                              3,351
                   1
  Other Activities                                                                      -                                  2
                                                                                                          6                                 22
                                                                                     (186)                              (660)
  Intersegment eliminations                                                                            (164)                              (667)
 Total                                                                              1,760             1,430            6,444             5,778

 Operating Profit (Loss)
                                                                                       30                                 133
  Advanced Engineered Materials                                                                          29                                   145
                                                                                       69                                 199
  Consumer Specialties                                                                                   41                                   165
                                                                                       26                                  28
  Industrial Specialties                                                                                  9                                    44
                                                                                      276                                 616
  Acetyl Intermediates                                                                                  107                                   456
                   1
  Other Activities                                                                    (77)                               (228)
                                                                                                        (46)                                 (190)
 Total                                                                                324               140               748                 620


 Equity Earnings and Other Income/(Expense) 2
                                                                                        7                                 55
  Advanced Engineered Materials                                                                          13                                   55
                                                                                        3                                 40
  Consumer Specialties                                                                                    2                                   24
                                                                                        -                                  -
  Industrial Specialties                                                                                  -                                   (1)
                                                                                       27                                 78
  Acetyl Intermediates                                                                                   23                                   63
                   1
  Other Activities                                                                      8                                  -
                                                                                                         12                                   22
 Total                                                                                 45                50              173                 163


 Other Charges and Other Adjustments 3
                                                                                      (10)                                (5)
  Advanced Engineered Materials                                                                          (1)                                  (5)
                                                                                      (27)                               (16)
  Consumer Specialties                                                                                    -                                    -
                                                                                       (1)                                32
  Industrial Specialties                                                                                  2                                   16
                                                                                      (97)                               (38)
  Acetyl Intermediates                                                                                   16                                   52
                   1
  Other Activities                                                                     42                                140
                                                                                                         (2)                                  29
 Total                                                                                (93)               15              113                  92

 Depreciation and Amortization Expense
                                                                                       18                                 69
  Advanced Engineered Materials                                                                          17                                   65
                                                                                       12                                 51
  Consumer Specialties                                                                                   10                                   39
                                                                                                                                                     Reg G: Reconciliation of Operating




                                                                                       16                                 59
  Industrial Specialties                                                                                 14                                   59
                                                                                       25                                106
  Acetyl Intermediates                                                                                   23                                  101
                   1
  Other Activities                                                                                        -                                    5
                                                                                                                           6
                                                                                        2
 Total                                                                                 73                64              291                 269

 Operating EBITDA
                                                                                       45                                252
  Advanced Engineered Materials                                                                          58                                260
                                                                                       57                                274
  Consumer Specialties                                                                                   53                                228
                                                                                       41                                119
  Industrial Specialties                                                                                 25                                118
                                                                                      231                                762
  Acetyl Intermediates                                                                                  169                                672
                   1
  Other Activities                                                                    (25)                               (82)
                                                                                                        (36)                              (134)
 Total                                                                                349               269            1,325             1,144
 1
     Other Activities primarily includes corporate selling, general and administrative expenses and the results from captive insurance companies.
     The 2007 Operating Profit (Loss) and Other Charges and Other Adjustments amounts include deductible associated with insurance recovery.
 2
     Includes equity earnings from affiliates, dividends from cost investments and other income/(expense).
 3
     Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations (See Table 7).
celanese 2008_may_roadshow_presentation_final-2
celanese 2008_may_roadshow_presentation_final-2
celanese 2008_may_roadshow_presentation_final-2

Weitere ähnliche Inhalte

Was ist angesagt?

Finningpresentation uk sep 2011_final
Finningpresentation uk sep 2011_finalFinningpresentation uk sep 2011_final
Finningpresentation uk sep 2011_finalFinningInternational
 
celanese investor_fact_sheet_q3_08
celanese investor_fact_sheet_q3_08celanese investor_fact_sheet_q3_08
celanese investor_fact_sheet_q3_08finance44
 
Pembina Corporate Presentation
Pembina Corporate PresentationPembina Corporate Presentation
Pembina Corporate PresentationCompany Spotlight
 
celanese q3_earnings_presentation
celanese q3_earnings_presentationcelanese q3_earnings_presentation
celanese q3_earnings_presentationfinance44
 
arvinmeritor Bear_Stearns_Conf_050707_ARM_FINAL
arvinmeritor Bear_Stearns_Conf_050707_ARM_FINALarvinmeritor Bear_Stearns_Conf_050707_ARM_FINAL
arvinmeritor Bear_Stearns_Conf_050707_ARM_FINALfinance27
 
The Extraprise - Using Collaborative Commerce to Extend the Value of Your ER...
The Extraprise -  Using Collaborative Commerce to Extend the Value of Your ER...The Extraprise -  Using Collaborative Commerce to Extend the Value of Your ER...
The Extraprise - Using Collaborative Commerce to Extend the Value of Your ER...SAP Ariba
 
Dow Accelerates Implementation of its Transformational Strategy Presentation
Dow Accelerates Implementation of its Transformational Strategy PresentationDow Accelerates Implementation of its Transformational Strategy Presentation
Dow Accelerates Implementation of its Transformational Strategy Presentationfinance5
 
df library.corporate-ir.
 df library.corporate-ir. df library.corporate-ir.
df library.corporate-ir.finance23
 
Heizer om10 ch16-jit and lean operations
Heizer om10 ch16-jit and lean operationsHeizer om10 ch16-jit and lean operations
Heizer om10 ch16-jit and lean operationsRozaimi Mohd Saad
 
agilent 03CorporateReport
agilent  03CorporateReportagilent  03CorporateReport
agilent 03CorporateReportfinance38
 
Heizer om10 ch11-supply chain
Heizer om10 ch11-supply chainHeizer om10 ch11-supply chain
Heizer om10 ch11-supply chainRozaimi Mohd Saad
 
celanese 2007_investor_day_-_complete
celanese 2007_investor_day_-_completecelanese 2007_investor_day_-_complete
celanese 2007_investor_day_-_completefinance44
 
Merrill Lynch Global Power & Gas Leaders Presentation
Merrill Lynch Global Power & Gas Leaders PresentationMerrill Lynch Global Power & Gas Leaders Presentation
Merrill Lynch Global Power & Gas Leaders Presentationfinance14
 
public serviceenterprise group Morgan Stanley FINAL
public serviceenterprise group Morgan Stanley FINALpublic serviceenterprise group Morgan Stanley FINAL
public serviceenterprise group Morgan Stanley FINALfinance20
 

Was ist angesagt? (17)

Finningpresentation uk sep 2011_final
Finningpresentation uk sep 2011_finalFinningpresentation uk sep 2011_final
Finningpresentation uk sep 2011_final
 
celanese investor_fact_sheet_q3_08
celanese investor_fact_sheet_q3_08celanese investor_fact_sheet_q3_08
celanese investor_fact_sheet_q3_08
 
Pembina Corporate Presentation
Pembina Corporate PresentationPembina Corporate Presentation
Pembina Corporate Presentation
 
celanese q3_earnings_presentation
celanese q3_earnings_presentationcelanese q3_earnings_presentation
celanese q3_earnings_presentation
 
arvinmeritor Bear_Stearns_Conf_050707_ARM_FINAL
arvinmeritor Bear_Stearns_Conf_050707_ARM_FINALarvinmeritor Bear_Stearns_Conf_050707_ARM_FINAL
arvinmeritor Bear_Stearns_Conf_050707_ARM_FINAL
 
The Extraprise - Using Collaborative Commerce to Extend the Value of Your ER...
The Extraprise -  Using Collaborative Commerce to Extend the Value of Your ER...The Extraprise -  Using Collaborative Commerce to Extend the Value of Your ER...
The Extraprise - Using Collaborative Commerce to Extend the Value of Your ER...
 
Dow Accelerates Implementation of its Transformational Strategy Presentation
Dow Accelerates Implementation of its Transformational Strategy PresentationDow Accelerates Implementation of its Transformational Strategy Presentation
Dow Accelerates Implementation of its Transformational Strategy Presentation
 
df library.corporate-ir.
 df library.corporate-ir. df library.corporate-ir.
df library.corporate-ir.
 
Heizer om10 ch16-jit and lean operations
Heizer om10 ch16-jit and lean operationsHeizer om10 ch16-jit and lean operations
Heizer om10 ch16-jit and lean operations
 
agilent 03CorporateReport
agilent  03CorporateReportagilent  03CorporateReport
agilent 03CorporateReport
 
Heizer om10 ch11-supply chain
Heizer om10 ch11-supply chainHeizer om10 ch11-supply chain
Heizer om10 ch11-supply chain
 
Heizer Chapter 02
Heizer Chapter 02 Heizer Chapter 02
Heizer Chapter 02
 
Heizer Chapter ch02
Heizer Chapter  ch02Heizer Chapter  ch02
Heizer Chapter ch02
 
Latest Presentation
Latest PresentationLatest Presentation
Latest Presentation
 
celanese 2007_investor_day_-_complete
celanese 2007_investor_day_-_completecelanese 2007_investor_day_-_complete
celanese 2007_investor_day_-_complete
 
Merrill Lynch Global Power & Gas Leaders Presentation
Merrill Lynch Global Power & Gas Leaders PresentationMerrill Lynch Global Power & Gas Leaders Presentation
Merrill Lynch Global Power & Gas Leaders Presentation
 
public serviceenterprise group Morgan Stanley FINAL
public serviceenterprise group Morgan Stanley FINALpublic serviceenterprise group Morgan Stanley FINAL
public serviceenterprise group Morgan Stanley FINAL
 

Andere mochten auch

celanese investor_day_2006_complete_presentation
celanese investor_day_2006_complete_presentationcelanese investor_day_2006_complete_presentation
celanese investor_day_2006_complete_presentationfinance44
 
oshkosh Q306_Presentation
oshkosh   Q306_Presentationoshkosh   Q306_Presentation
oshkosh Q306_Presentationfinance44
 
oshkosh Q206_Earnings_Presentation
oshkosh   Q206_Earnings_Presentationoshkosh   Q206_Earnings_Presentation
oshkosh Q206_Earnings_Presentationfinance44
 
oshkosh Q106_Presentation
oshkosh   Q106_Presentationoshkosh   Q106_Presentation
oshkosh Q106_Presentationfinance44
 

Andere mochten auch (6)

celanese investor_day_2006_complete_presentation
celanese investor_day_2006_complete_presentationcelanese investor_day_2006_complete_presentation
celanese investor_day_2006_complete_presentation
 
Oshkosh
OshkoshOshkosh
Oshkosh
 
OSK_101606
OSK_101606OSK_101606
OSK_101606
 
oshkosh Q306_Presentation
oshkosh   Q306_Presentationoshkosh   Q306_Presentation
oshkosh Q306_Presentation
 
oshkosh Q206_Earnings_Presentation
oshkosh   Q206_Earnings_Presentationoshkosh   Q206_Earnings_Presentation
oshkosh Q206_Earnings_Presentation
 
oshkosh Q106_Presentation
oshkosh   Q106_Presentationoshkosh   Q106_Presentation
oshkosh Q106_Presentation
 

Ähnlich wie celanese 2008_may_roadshow_presentation_final-2

celanese 2008_september_roadshow_presentation
celanese 2008_september_roadshow_presentationcelanese 2008_september_roadshow_presentation
celanese 2008_september_roadshow_presentationfinance44
 
celanese 2008_may_roadshow_presentation_final
celanese 2008_may_roadshow_presentation_finalcelanese 2008_may_roadshow_presentation_final
celanese 2008_may_roadshow_presentation_finalfinance44
 
celanese sept_20th_china_investor_presentation_final-4
celanese sept_20th_china_investor_presentation_final-4celanese sept_20th_china_investor_presentation_final-4
celanese sept_20th_china_investor_presentation_final-4finance44
 
celanese_roadshow_august_2007final_8_28_07
celanese_roadshow_august_2007final_8_28_07celanese_roadshow_august_2007final_8_28_07
celanese_roadshow_august_2007final_8_28_07finance44
 
celanese q2_2008_presentation
celanese q2_2008_presentationcelanese q2_2008_presentation
celanese q2_2008_presentationfinance44
 
celanese q2_2008_presentation
celanese q2_2008_presentationcelanese q2_2008_presentation
celanese q2_2008_presentationfinance44
 
q2_2008_presentation
q2_2008_presentationq2_2008_presentation
q2_2008_presentationfinance44
 
Performanceleadership
PerformanceleadershipPerformanceleadership
Performanceleadershipmaxvink
 
celanese investor_fact_sheet
celanese investor_fact_sheetcelanese investor_fact_sheet
celanese investor_fact_sheetfinance44
 
celanese investor_fact_sheet
celanese  investor_fact_sheetcelanese  investor_fact_sheet
celanese investor_fact_sheetfinance44
 
Operating Model
Operating ModelOperating Model
Operating Modelrmuse70
 
celanese investor_fact_sheet_q3_08
celanese investor_fact_sheet_q3_08celanese investor_fact_sheet_q3_08
celanese investor_fact_sheet_q3_08finance44
 
celanese q4_2005_ir_slides
celanese q4_2005_ir_slidescelanese q4_2005_ir_slides
celanese q4_2005_ir_slidesfinance44
 
Dynamic matjan13presentation
Dynamic matjan13presentationDynamic matjan13presentation
Dynamic matjan13presentationCompany Spotlight
 
3/2/07 DF Special Dividend ConferenceCallSlides
3/2/07 DF Special Dividend ConferenceCallSlides3/2/07 DF Special Dividend ConferenceCallSlides
3/2/07 DF Special Dividend ConferenceCallSlidesfinance23
 
celanese q2_2007_earnings_pres
celanese q2_2007_earnings_prescelanese q2_2007_earnings_pres
celanese q2_2007_earnings_presfinance44
 
Territory management for inside sales leader notes
Territory management for inside sales leader notesTerritory management for inside sales leader notes
Territory management for inside sales leader notesFitira
 
public serviceenterprise group CapReIzzo
public serviceenterprise group CapReIzzopublic serviceenterprise group CapReIzzo
public serviceenterprise group CapReIzzofinance20
 
public serviceenterprise group CapReIzzo
public serviceenterprise group CapReIzzopublic serviceenterprise group CapReIzzo
public serviceenterprise group CapReIzzofinance20
 
Balanced Scorecard Presentation For Gemba
Balanced Scorecard Presentation For GembaBalanced Scorecard Presentation For Gemba
Balanced Scorecard Presentation For GembaBenjamin Shobert
 

Ähnlich wie celanese 2008_may_roadshow_presentation_final-2 (20)

celanese 2008_september_roadshow_presentation
celanese 2008_september_roadshow_presentationcelanese 2008_september_roadshow_presentation
celanese 2008_september_roadshow_presentation
 
celanese 2008_may_roadshow_presentation_final
celanese 2008_may_roadshow_presentation_finalcelanese 2008_may_roadshow_presentation_final
celanese 2008_may_roadshow_presentation_final
 
celanese sept_20th_china_investor_presentation_final-4
celanese sept_20th_china_investor_presentation_final-4celanese sept_20th_china_investor_presentation_final-4
celanese sept_20th_china_investor_presentation_final-4
 
celanese_roadshow_august_2007final_8_28_07
celanese_roadshow_august_2007final_8_28_07celanese_roadshow_august_2007final_8_28_07
celanese_roadshow_august_2007final_8_28_07
 
celanese q2_2008_presentation
celanese q2_2008_presentationcelanese q2_2008_presentation
celanese q2_2008_presentation
 
celanese q2_2008_presentation
celanese q2_2008_presentationcelanese q2_2008_presentation
celanese q2_2008_presentation
 
q2_2008_presentation
q2_2008_presentationq2_2008_presentation
q2_2008_presentation
 
Performanceleadership
PerformanceleadershipPerformanceleadership
Performanceleadership
 
celanese investor_fact_sheet
celanese investor_fact_sheetcelanese investor_fact_sheet
celanese investor_fact_sheet
 
celanese investor_fact_sheet
celanese  investor_fact_sheetcelanese  investor_fact_sheet
celanese investor_fact_sheet
 
Operating Model
Operating ModelOperating Model
Operating Model
 
celanese investor_fact_sheet_q3_08
celanese investor_fact_sheet_q3_08celanese investor_fact_sheet_q3_08
celanese investor_fact_sheet_q3_08
 
celanese q4_2005_ir_slides
celanese q4_2005_ir_slidescelanese q4_2005_ir_slides
celanese q4_2005_ir_slides
 
Dynamic matjan13presentation
Dynamic matjan13presentationDynamic matjan13presentation
Dynamic matjan13presentation
 
3/2/07 DF Special Dividend ConferenceCallSlides
3/2/07 DF Special Dividend ConferenceCallSlides3/2/07 DF Special Dividend ConferenceCallSlides
3/2/07 DF Special Dividend ConferenceCallSlides
 
celanese q2_2007_earnings_pres
celanese q2_2007_earnings_prescelanese q2_2007_earnings_pres
celanese q2_2007_earnings_pres
 
Territory management for inside sales leader notes
Territory management for inside sales leader notesTerritory management for inside sales leader notes
Territory management for inside sales leader notes
 
public serviceenterprise group CapReIzzo
public serviceenterprise group CapReIzzopublic serviceenterprise group CapReIzzo
public serviceenterprise group CapReIzzo
 
public serviceenterprise group CapReIzzo
public serviceenterprise group CapReIzzopublic serviceenterprise group CapReIzzo
public serviceenterprise group CapReIzzo
 
Balanced Scorecard Presentation For Gemba
Balanced Scorecard Presentation For GembaBalanced Scorecard Presentation For Gemba
Balanced Scorecard Presentation For Gemba
 

Mehr von finance44

oshkosh Q107_Slides
oshkosh   Q107_Slidesoshkosh   Q107_Slides
oshkosh Q107_Slidesfinance44
 
oshkosh Q207_Slides
oshkosh   Q207_Slidesoshkosh   Q207_Slides
oshkosh Q207_Slidesfinance44
 
oshkosh Q32007slides
oshkosh   Q32007slidesoshkosh   Q32007slides
oshkosh Q32007slidesfinance44
 
oshkosh Q407_Earnings
oshkosh   Q407_Earningsoshkosh   Q407_Earnings
oshkosh Q407_Earningsfinance44
 
oshkosh Q108_earnings_slides
oshkosh   Q108_earnings_slidesoshkosh   Q108_earnings_slides
oshkosh Q108_earnings_slidesfinance44
 
oshkosh Q208_Slides
oshkosh   Q208_Slidesoshkosh   Q208_Slides
oshkosh Q208_Slidesfinance44
 
oshkosh Q308_Slides
oshkosh   Q308_Slidesoshkosh   Q308_Slides
oshkosh Q308_Slidesfinance44
 
OSK_Q4_2008_Earnings_Release_Slides
OSK_Q4_2008_Earnings_Release_SlidesOSK_Q4_2008_Earnings_Release_Slides
OSK_Q4_2008_Earnings_Release_Slidesfinance44
 
oshkosh Goldman_110508
oshkosh   Goldman_110508oshkosh   Goldman_110508
oshkosh Goldman_110508finance44
 
oshkosh Baird_111208
oshkosh   Baird_111208oshkosh   Baird_111208
oshkosh Baird_111208finance44
 
oshkosh B9FAB733-F810-4AE7-A95B-4388C6B08318_Cowen_020509
oshkosh   B9FAB733-F810-4AE7-A95B-4388C6B08318_Cowen_020509oshkosh   B9FAB733-F810-4AE7-A95B-4388C6B08318_Cowen_020509
oshkosh B9FAB733-F810-4AE7-A95B-4388C6B08318_Cowen_020509finance44
 
oshkosh Q108_earnings_slides
oshkosh   Q108_earnings_slidesoshkosh   Q108_earnings_slides
oshkosh Q108_earnings_slidesfinance44
 
oshkosh Q208_Slides
oshkosh   Q208_Slidesoshkosh   Q208_Slides
oshkosh Q208_Slidesfinance44
 
oshkosh Q308_Slides
oshkosh   Q308_Slidesoshkosh   Q308_Slides
oshkosh Q308_Slidesfinance44
 
oshkosh OSK_Q4_2008_Earnings_Release_Slides
oshkosh   OSK_Q4_2008_Earnings_Release_Slidesoshkosh   OSK_Q4_2008_Earnings_Release_Slides
oshkosh OSK_Q4_2008_Earnings_Release_Slidesfinance44
 
goodrich AllMasterBW
goodrich  AllMasterBWgoodrich  AllMasterBW
goodrich AllMasterBWfinance44
 
goodrich AllMasterBW
goodrich  AllMasterBWgoodrich  AllMasterBW
goodrich AllMasterBWfinance44
 
goodrich MasterJefferiesConfFinal
goodrich  MasterJefferiesConfFinalgoodrich  MasterJefferiesConfFinal
goodrich MasterJefferiesConfFinalfinance44
 
goodrich MasterJefferiesConfFinal
goodrich  MasterJefferiesConfFinalgoodrich  MasterJefferiesConfFinal
goodrich MasterJefferiesConfFinalfinance44
 
goodrich Q403ReleaseFinal
goodrich  Q403ReleaseFinalgoodrich  Q403ReleaseFinal
goodrich Q403ReleaseFinalfinance44
 

Mehr von finance44 (20)

oshkosh Q107_Slides
oshkosh   Q107_Slidesoshkosh   Q107_Slides
oshkosh Q107_Slides
 
oshkosh Q207_Slides
oshkosh   Q207_Slidesoshkosh   Q207_Slides
oshkosh Q207_Slides
 
oshkosh Q32007slides
oshkosh   Q32007slidesoshkosh   Q32007slides
oshkosh Q32007slides
 
oshkosh Q407_Earnings
oshkosh   Q407_Earningsoshkosh   Q407_Earnings
oshkosh Q407_Earnings
 
oshkosh Q108_earnings_slides
oshkosh   Q108_earnings_slidesoshkosh   Q108_earnings_slides
oshkosh Q108_earnings_slides
 
oshkosh Q208_Slides
oshkosh   Q208_Slidesoshkosh   Q208_Slides
oshkosh Q208_Slides
 
oshkosh Q308_Slides
oshkosh   Q308_Slidesoshkosh   Q308_Slides
oshkosh Q308_Slides
 
OSK_Q4_2008_Earnings_Release_Slides
OSK_Q4_2008_Earnings_Release_SlidesOSK_Q4_2008_Earnings_Release_Slides
OSK_Q4_2008_Earnings_Release_Slides
 
oshkosh Goldman_110508
oshkosh   Goldman_110508oshkosh   Goldman_110508
oshkosh Goldman_110508
 
oshkosh Baird_111208
oshkosh   Baird_111208oshkosh   Baird_111208
oshkosh Baird_111208
 
oshkosh B9FAB733-F810-4AE7-A95B-4388C6B08318_Cowen_020509
oshkosh   B9FAB733-F810-4AE7-A95B-4388C6B08318_Cowen_020509oshkosh   B9FAB733-F810-4AE7-A95B-4388C6B08318_Cowen_020509
oshkosh B9FAB733-F810-4AE7-A95B-4388C6B08318_Cowen_020509
 
oshkosh Q108_earnings_slides
oshkosh   Q108_earnings_slidesoshkosh   Q108_earnings_slides
oshkosh Q108_earnings_slides
 
oshkosh Q208_Slides
oshkosh   Q208_Slidesoshkosh   Q208_Slides
oshkosh Q208_Slides
 
oshkosh Q308_Slides
oshkosh   Q308_Slidesoshkosh   Q308_Slides
oshkosh Q308_Slides
 
oshkosh OSK_Q4_2008_Earnings_Release_Slides
oshkosh   OSK_Q4_2008_Earnings_Release_Slidesoshkosh   OSK_Q4_2008_Earnings_Release_Slides
oshkosh OSK_Q4_2008_Earnings_Release_Slides
 
goodrich AllMasterBW
goodrich  AllMasterBWgoodrich  AllMasterBW
goodrich AllMasterBW
 
goodrich AllMasterBW
goodrich  AllMasterBWgoodrich  AllMasterBW
goodrich AllMasterBW
 
goodrich MasterJefferiesConfFinal
goodrich  MasterJefferiesConfFinalgoodrich  MasterJefferiesConfFinal
goodrich MasterJefferiesConfFinal
 
goodrich MasterJefferiesConfFinal
goodrich  MasterJefferiesConfFinalgoodrich  MasterJefferiesConfFinal
goodrich MasterJefferiesConfFinal
 
goodrich Q403ReleaseFinal
goodrich  Q403ReleaseFinalgoodrich  Q403ReleaseFinal
goodrich Q403ReleaseFinal
 

Kürzlich hochgeladen

Money Forward Integrated Report “Forward Map” 2024
Money Forward Integrated Report “Forward Map” 2024Money Forward Integrated Report “Forward Map” 2024
Money Forward Integrated Report “Forward Map” 2024Money Forward
 
Aon-UK-DC-Pension-Tracker-Q1-2024. slideshare
Aon-UK-DC-Pension-Tracker-Q1-2024. slideshareAon-UK-DC-Pension-Tracker-Q1-2024. slideshare
Aon-UK-DC-Pension-Tracker-Q1-2024. slideshareHenry Tapper
 
Building pressure? Rising rents, and what to expect in the future
Building pressure? Rising rents, and what to expect in the futureBuilding pressure? Rising rents, and what to expect in the future
Building pressure? Rising rents, and what to expect in the futureResolutionFoundation
 
Global Economic Outlook, 2024 - Scholaride Consulting
Global Economic Outlook, 2024 - Scholaride ConsultingGlobal Economic Outlook, 2024 - Scholaride Consulting
Global Economic Outlook, 2024 - Scholaride Consultingswastiknandyofficial
 
Hello this ppt is about seminar final project
Hello this ppt is about seminar final projectHello this ppt is about seminar final project
Hello this ppt is about seminar final projectninnasirsi
 
What is sip and What are its Benefits in 2024
What is sip and What are its Benefits in 2024What is sip and What are its Benefits in 2024
What is sip and What are its Benefits in 2024prajwalgopocket
 
Crypto Confidence Unlocked: AnyKYCaccount's Shortcut to Binance Verification
Crypto Confidence Unlocked: AnyKYCaccount's Shortcut to Binance VerificationCrypto Confidence Unlocked: AnyKYCaccount's Shortcut to Binance Verification
Crypto Confidence Unlocked: AnyKYCaccount's Shortcut to Binance VerificationAny kyc Account
 
OAT_RI_Ep18 WeighingTheRisks_Mar24_GlobalCredit.pptx
OAT_RI_Ep18 WeighingTheRisks_Mar24_GlobalCredit.pptxOAT_RI_Ep18 WeighingTheRisks_Mar24_GlobalCredit.pptx
OAT_RI_Ep18 WeighingTheRisks_Mar24_GlobalCredit.pptxhiddenlevers
 
10 QuickBooks Tips 2024 - Globus Finanza.pdf
10 QuickBooks Tips 2024 - Globus Finanza.pdf10 QuickBooks Tips 2024 - Globus Finanza.pdf
10 QuickBooks Tips 2024 - Globus Finanza.pdfglobusfinanza
 
Thoma Bravo Equity - Presentation Pension Fund
Thoma Bravo Equity - Presentation Pension FundThoma Bravo Equity - Presentation Pension Fund
Thoma Bravo Equity - Presentation Pension FundAshwinJey
 
ΤτΕ: Ανάπτυξη 2,3% και πληθωρισμός 2,8% φέτος
ΤτΕ: Ανάπτυξη 2,3% και πληθωρισμός 2,8% φέτοςΤτΕ: Ανάπτυξη 2,3% και πληθωρισμός 2,8% φέτος
ΤτΕ: Ανάπτυξη 2,3% και πληθωρισμός 2,8% φέτοςNewsroom8
 
The Inspirational Story of Julio Herrera Velutini - Global Finance Leader
The Inspirational Story of Julio Herrera Velutini - Global Finance LeaderThe Inspirational Story of Julio Herrera Velutini - Global Finance Leader
The Inspirational Story of Julio Herrera Velutini - Global Finance LeaderArianna Varetto
 
Banking: Commercial and Central Banking.pptx
Banking: Commercial and Central Banking.pptxBanking: Commercial and Central Banking.pptx
Banking: Commercial and Central Banking.pptxANTHONYAKINYOSOYE1
 
Gender and caste discrimination in india
Gender and caste discrimination in indiaGender and caste discrimination in india
Gender and caste discrimination in indiavandanasingh01072003
 
2B Nation-State.pptx contemporary world nation
2B  Nation-State.pptx contemporary world nation2B  Nation-State.pptx contemporary world nation
2B Nation-State.pptx contemporary world nationko9240888
 
2024-04-09 - Pension Playpen roundtable - slides.pptx
2024-04-09 - Pension Playpen roundtable - slides.pptx2024-04-09 - Pension Playpen roundtable - slides.pptx
2024-04-09 - Pension Playpen roundtable - slides.pptxHenry Tapper
 
Kempen ' UK DB Endgame Paper Apr 24 final3.pdf
Kempen ' UK DB Endgame Paper Apr 24 final3.pdfKempen ' UK DB Endgame Paper Apr 24 final3.pdf
Kempen ' UK DB Endgame Paper Apr 24 final3.pdfHenry Tapper
 
ekthesi-trapeza-tis-ellados-gia-2023.pdf
ekthesi-trapeza-tis-ellados-gia-2023.pdfekthesi-trapeza-tis-ellados-gia-2023.pdf
ekthesi-trapeza-tis-ellados-gia-2023.pdfSteliosTheodorou4
 
Introduction to Health Economics Dr. R. Kurinji Malar.pptx
Introduction to Health Economics Dr. R. Kurinji Malar.pptxIntroduction to Health Economics Dr. R. Kurinji Malar.pptx
Introduction to Health Economics Dr. R. Kurinji Malar.pptxDrRkurinjiMalarkurin
 
Liquidity Decisions in Financial management
Liquidity Decisions in Financial managementLiquidity Decisions in Financial management
Liquidity Decisions in Financial managementshrutisingh143670
 

Kürzlich hochgeladen (20)

Money Forward Integrated Report “Forward Map” 2024
Money Forward Integrated Report “Forward Map” 2024Money Forward Integrated Report “Forward Map” 2024
Money Forward Integrated Report “Forward Map” 2024
 
Aon-UK-DC-Pension-Tracker-Q1-2024. slideshare
Aon-UK-DC-Pension-Tracker-Q1-2024. slideshareAon-UK-DC-Pension-Tracker-Q1-2024. slideshare
Aon-UK-DC-Pension-Tracker-Q1-2024. slideshare
 
Building pressure? Rising rents, and what to expect in the future
Building pressure? Rising rents, and what to expect in the futureBuilding pressure? Rising rents, and what to expect in the future
Building pressure? Rising rents, and what to expect in the future
 
Global Economic Outlook, 2024 - Scholaride Consulting
Global Economic Outlook, 2024 - Scholaride ConsultingGlobal Economic Outlook, 2024 - Scholaride Consulting
Global Economic Outlook, 2024 - Scholaride Consulting
 
Hello this ppt is about seminar final project
Hello this ppt is about seminar final projectHello this ppt is about seminar final project
Hello this ppt is about seminar final project
 
What is sip and What are its Benefits in 2024
What is sip and What are its Benefits in 2024What is sip and What are its Benefits in 2024
What is sip and What are its Benefits in 2024
 
Crypto Confidence Unlocked: AnyKYCaccount's Shortcut to Binance Verification
Crypto Confidence Unlocked: AnyKYCaccount's Shortcut to Binance VerificationCrypto Confidence Unlocked: AnyKYCaccount's Shortcut to Binance Verification
Crypto Confidence Unlocked: AnyKYCaccount's Shortcut to Binance Verification
 
OAT_RI_Ep18 WeighingTheRisks_Mar24_GlobalCredit.pptx
OAT_RI_Ep18 WeighingTheRisks_Mar24_GlobalCredit.pptxOAT_RI_Ep18 WeighingTheRisks_Mar24_GlobalCredit.pptx
OAT_RI_Ep18 WeighingTheRisks_Mar24_GlobalCredit.pptx
 
10 QuickBooks Tips 2024 - Globus Finanza.pdf
10 QuickBooks Tips 2024 - Globus Finanza.pdf10 QuickBooks Tips 2024 - Globus Finanza.pdf
10 QuickBooks Tips 2024 - Globus Finanza.pdf
 
Thoma Bravo Equity - Presentation Pension Fund
Thoma Bravo Equity - Presentation Pension FundThoma Bravo Equity - Presentation Pension Fund
Thoma Bravo Equity - Presentation Pension Fund
 
ΤτΕ: Ανάπτυξη 2,3% και πληθωρισμός 2,8% φέτος
ΤτΕ: Ανάπτυξη 2,3% και πληθωρισμός 2,8% φέτοςΤτΕ: Ανάπτυξη 2,3% και πληθωρισμός 2,8% φέτος
ΤτΕ: Ανάπτυξη 2,3% και πληθωρισμός 2,8% φέτος
 
The Inspirational Story of Julio Herrera Velutini - Global Finance Leader
The Inspirational Story of Julio Herrera Velutini - Global Finance LeaderThe Inspirational Story of Julio Herrera Velutini - Global Finance Leader
The Inspirational Story of Julio Herrera Velutini - Global Finance Leader
 
Banking: Commercial and Central Banking.pptx
Banking: Commercial and Central Banking.pptxBanking: Commercial and Central Banking.pptx
Banking: Commercial and Central Banking.pptx
 
Gender and caste discrimination in india
Gender and caste discrimination in indiaGender and caste discrimination in india
Gender and caste discrimination in india
 
2B Nation-State.pptx contemporary world nation
2B  Nation-State.pptx contemporary world nation2B  Nation-State.pptx contemporary world nation
2B Nation-State.pptx contemporary world nation
 
2024-04-09 - Pension Playpen roundtable - slides.pptx
2024-04-09 - Pension Playpen roundtable - slides.pptx2024-04-09 - Pension Playpen roundtable - slides.pptx
2024-04-09 - Pension Playpen roundtable - slides.pptx
 
Kempen ' UK DB Endgame Paper Apr 24 final3.pdf
Kempen ' UK DB Endgame Paper Apr 24 final3.pdfKempen ' UK DB Endgame Paper Apr 24 final3.pdf
Kempen ' UK DB Endgame Paper Apr 24 final3.pdf
 
ekthesi-trapeza-tis-ellados-gia-2023.pdf
ekthesi-trapeza-tis-ellados-gia-2023.pdfekthesi-trapeza-tis-ellados-gia-2023.pdf
ekthesi-trapeza-tis-ellados-gia-2023.pdf
 
Introduction to Health Economics Dr. R. Kurinji Malar.pptx
Introduction to Health Economics Dr. R. Kurinji Malar.pptxIntroduction to Health Economics Dr. R. Kurinji Malar.pptx
Introduction to Health Economics Dr. R. Kurinji Malar.pptx
 
Liquidity Decisions in Financial management
Liquidity Decisions in Financial managementLiquidity Decisions in Financial management
Liquidity Decisions in Financial management
 

celanese 2008_may_roadshow_presentation_final-2

  • 1. Celanese Corporation May 2008 1
  • 2. Forward looking statements; Reconciliation and use of non-GAAP measures to U.S. GAAP This presentation may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this presentation, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. This presentation reflects three performance measures, operating EBITDA, adjusted earnings per share and adjusted free cash flow as non-U.S. GAAP measures. The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for operating EBITDA is operating profit; for adjusted earnings per share is earnings per common share-diluted; and for adjusted free cash flow is cash flow from operations. ►Operating EBITDA, a measure used by management to measure performance, is defined as operating profit from continuing operations, plus equity in net earnings from affiliates, other income and depreciation and amortization, and further adjusted for other charges and adjustments. We provide guidance on operating EBITDA and are unable to reconcile forecasted operating EBITDA to a GAAP financial measure because a forecast of other charges and other adjustments is not practical. Our management believes operating EBITDA is useful to investors because it is one of the primary measures our management uses for its planning and budgeting processes and to monitor and evaluate financial and operating results. Operating EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to operating profit as a measure of operating performance or to cash flow from operations as a measure of liquidity. Because not all companies use identical calculations, this presentation of operating EBITDA may not be comparable to other similarly titled measures of other companies. Additionally, operating EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not consider certain cash requirements such as interest payments, tax payments and debt service requirements nor does it represent the amount used in our debt covenants. ►Adjusted earnings per share is a measure used by management to measure performance. It is defined as net earnings (loss) available to common shareholders plus preferred dividends, adjusted for other charges and adjustments, and divided by the number of basic common shares, diluted preferred shares, and options valued using the treasury method. We provide guidance on an adjusted earnings per share basis and are unable to reconcile forecasted adjusted earnings per share to a GAAP financial measure because a forecast of other charges and other adjustments is not practical. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations, and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided with a more meaningful understanding of our ongoing operating performance. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information. ►The tax rate used for adjusted earnings per share is the tax rate based on our original guidance communicated at the company’s investor day in December 2007. We adjust this tax rate during the year only if there is a substantial change in our underlying operations; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate may differ significantly from the tax rate used for U.S. GAAP reporting in any given reporting period. It is not practical to reconcile our prospective adjusted tax rate to the actual U.S. GAAP tax rate in any future period. ►Adjusted free cash flow is defined as cash flow from operations less capital expenditures, other productive asset purchases, operating cash from discontinued operations and certain other charges. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding changes to the company’s cash flow. Our management and credit analysts use adjusted free cash flow to evaluate the company’s liquidity and assess credit quality. This non-U.S. GAAP measure is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information. 2
  • 3. Who is Celanese? Superior Value Creation Strategy Industry Leader Clear focus on growth and ► value creation Geographically balanced ● global positions Culture Diversified end market Leading Global ● Strong performance exposure Integrated Producer built on shared of Chemicals and Strong Cash Generation ► principles and Advanced Materials objectives Significant Growth ► Capability Execution Track record of execution ● Demonstrated track record Clearly defined ● of delivering results opportunities 3
  • 4. Globally balanced and integrated businesses aligned to accelerate growth Differentiated Intermediates Specialty Products Building Block Acetate Consumer Specialties Anhydride (CS) Nutrinova and esters Acetic Acid Emulsions Industrial Raw VAM PVOH Specialties Materials (IS) AT Plastics Formaldehyde Ticona Advanced Engineering Acetyl Intermediates Engineered Polymers (AI) Materials (AEM) Affiliates 4
  • 5. Today’s portfolio: higher growth, more specialty 2007 Financial Highlights: ► Operating EBITDA1 Net sales - $6,444 million ● Operating EBITDA - $1,325 million Advanced Engineered Materials ● Consumer and Industrial Specialties Strategic growth plans ► Acetyl Intermediates 1,400 continue to accelerate earnings of specialty 1,200 businesses 1,000 Essentially all growth has come from ● $ in millions specialty businesses 800 Two-thirds of 2010 Growth ● Objectives expected from specialty 600 businesses Resulting in: 400 ► Higher growth rates ● 200 Increased overall earnings power of ● the portfolio - Reduced volatility ● 2005 2006 2007 1Operating EBITDA excludes Other Activities of ($122), ($134) and ($82) respectively for the periods presented 5
  • 6. Committed to delivering value creation Primary Growth Focus Balance Operational EBITDA Group Asia Revitalization Innovation Organic Sheet Excellence Impact Consumer and EPS Operating EBITDA Industrial X X X X >$100MM Specialties Advanced Engineered X X X X >$100MM Materials Acetyl X X X >$100MM Intermediates Celanese Incremental X X Corporate EPS $350 – $400 million increased EBITDA profile plus EPS potential by 2010 6
  • 7. On track and clear path forward to accelerate 2010 Growth Objectives Operating EBITDA Growth Objectives Advanced Engineered Materials 400 AEM: volume growth > 2X GDP Consumer and Industrial Specialties ► Acetyl Intermediates through further penetration CIS: Acetate continues ► $ in millions execution on revitalization 200 strategy; Emulsions/PVOH revitalization commences AI: Nanjing acetic acid plant ► startup leads integrated complex 0 2007 2008 2009 2010 7
  • 8. Asia strategy: high-return growth Celanese Nanjing Integrated Complex Investment Dynamics GUR® Celstran® Total investment: $300 - ► Warehouse Flare Unit Unit $350 million – over 80% complete Acetic Anhydride Vinyl Acetate Total revenue: $600 - $800 ► Unit Monomer Unit million when sold out by 2010 Incremental EBITDA: $120 - ► Acetic Acid Utilities / $150 million by 2010 Unit Tank Farm Emulsions Complex Administration & ROIC = 25 – 30% Compounding Maintenance 8
  • 9. AEM: value in technology and performance realized in price and positioned for growth $100 / kg Price for Performance $10 / kg $3 / kg $100/kg High-Performance Polymers (HPP) 5% $10/kg Engineering Thermoplastics (ETP) $3/kg others = 2% Performance Price Range Ranges PU = 6% 95% Standard Polymers $1/ kg PET = 7% ABS, SAN, ASA: 3% PS, EPS = 8% PVC = 17% PE = 31% PP = 21% $1/kg Range of Products 9
  • 10. AEM: significant opportunity for increased penetration in high growth region Advanced Engineered Materials Global Auto Production Type of Resins China Japan 6 2001 U.S. Germany 14 2007 India S. Korea 2010E 18 China production France nearly doubles Highest Brazil within 5 years 40 Current Spain Model Canada 2006 Production China 2.5 Trend Current Production Growth 2006-2012 Mexico 0 3,000 6,000 9,000 12,000 15,000 Pounds per Vehicle Vehicle Production (Thousand units) Source: Global Insight Source: Celanese Estimates 10
  • 11. AEM: megatrends driving growth for Vectra® LCP through LED lighting Customer Requirements High flow ► Low emissions ► Dimensional ► stability Pinpoint light ► Drivers: source Improved safety ► Lower energy consumption ► $5.1 billion $17.4 billion Miniaturization ► Aesthetics ► in 2006 in 2017 Design trends ► Audi A8 Audi R8 LED Street Lamps Applying Connector Daytime Running 54 LEDs per Expertise to New Lights Headlamp Technologies 11 Source: Philips
  • 12. IS: technology enhancements open $1.0 billion of new growth opportunities Global Vinyl Emulsions Applications Driving 2010 Growth 2010E Growth 4.0 Applications Application >25% Rate Sales ($MM) ~30% 3.0 $ in billions ~25% Low VOC and nano $400 – $500 10+% increase in paints 2.0 vinyl space Engineered $200 – $300 3% - 5% fabrics/glass fiber 1.0 Enviro-friendly $100 – $200 8% adhesives 0.0 2006 2010E China building/ $100 – $200 30+% construction Others Celanese $1.0 billion expansion = >$250 million in revenue 12
  • 13. IS: current regulatory trends enabling growth potential for VAE in U.S. VOC Regulatory Trends for European Interior Paint European VAE Success Flat to Semi-Gloss Paints Industry Development 50% VAE Share of Interior 1999 US VOC grams/liter EU VOC parts/liter VOC (g/L): 250 – 380 Paints VOC Content 2004 VOC (g/L): 100 – 150 0% European 1996 2006 2010E Standard Celanese Others 1990 2006 1999 2008 Current trends in U.S. following European precedent ► ► In 2008, Southern California will further restrict emission requirements in paints ► Today, less than 25% of the interior paints meet the contemplated guidelines $100 - $2001 per ton estimated cost for non-VAE emulsions to achieve standard ► U.S. interior paint opportunity ~$1.0 billion VAE provides favorable substitution for low-VOC requirements 1 Based on Celanese estimates 13
  • 14. AI: consumer trends support long-term growth 1-2% greater than GDP Acetyl Product Key Trends End Market Increased Demand Benefited Paints, coatings, inks and adhesives Emerging VAM, Esters used in residential and commercial Economies applications Acetic Acid, Acetic Demographics Pharmaceuticals Anhydride Increased demand for packaging films Affluence VAM (PVOH, EVOH) Convenience Films and polyester Acetic Acid, VAM Water Consumption of bottled water Acetic Acid Environmentally friendly paints and Environment VAM (for VAE) coatings 14
  • 15. AI: continued >GDP demand growth driven by each major end use Acetic Acid End-Use Growth Annual acetic acid ► (2000 – 2010) demand growth of ~4.5% through at least 2010 12,000 350 ► Each end market is China Acetic Acid Demand (indexed at 100) experiencing favorable CAGR 12% Acetic Acid Demand by End-Use, kta 300 10,000 demand expansion ► 2007 – 2010 estimated 250 8,000 CAGR: 200 VAM: 6% 6,000 150 PTA: 7% 4,000 Esters: 4% 100 Anhydride: 3% 2,000 50 0 0 2000 2004 2007 2010 Strong acetic acid VAM PTA Esters Anhydride Other China Demand continues through 2010 Source: Tecnon and Celanese Estimates, 2008 15
  • 16. AI: advantaged operating costs and favorable supply/demand continues through 2010 2010E Acetic Acid Cost Curve (kt) Acetic Acid Supply/Demand Balance (based on nameplate capacity) High Cost 12,000 Ethylene Low Cost High Cost Supply Demand Ethanol 10,000 8,000 Celanese Conventional Technology kt 6,000 MeOH/CO AOPlus™/Leading 4,000 Competition 2,000 By- prod 0 2004 2005 2006 2007 2008E 2009E 2010E Utilization of 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 Effective Capacity1(11/07 ): 91% 93% 92% 94% 93% 91% 91% 12008E-2010E effective utilization based on external analysis assumptions Source: Celanese estimates, available public data 16
  • 17. Recent initiatives to support growth beyond 2010 Recent Actions Direct to China ► Announced plans to add polymer compounding unit to the Nanjing Complex Advanced Commissioned start-up of Nanjing Celstran® unit Engineered Materials Kelsterbach relocation ► Announced 40% capacity expansion at new European POM facility Signed an agreement with Wison to double ► Nanjing CO supply increasing reliability and supporting future expansion Acetyl Announced agreement with SWRI, a leading Intermediates ► Chinese technology institute, to acquire technology licensing rights and development capabilities Recently announced authorization for $400 million share repurchase 17
  • 18. Strong cash flow generation enables future earnings growth Adjusted Free Cash Flow1 Strong operating results ► 550 - 600 456 Working capital productivity ► 385 $ in millions Decrease in overall borrowing ► costs since 2005 Continued improvement in ► interest coverage ratio 2006 2007 2008E Enhanced capital flexibility ► Operating EBITDA/Net Interest Bias for growth spending ► 7x 8.0% Borrowing Rate 6.5x 6x Maximize return to ► 6.1x 5x shareholders 4.5x 4x 3.9x 3x 2x 6.9% 1x 0x 2005 2006 2007 2008E 1 Adjustedfree cash flow calculated as cash flow from operations less capital expenditures less other productive asset purchases less operating 18 cash from discontinued operations plus certain other charges – 2008 estimate excludes Kelsterbach relocation
  • 19. Growth focused cash flow and capital structure strategy Cash Available for Strategic Use Execute Growth Strategy Optimize Capital Structure Cost Reduction Core/Bolt-on Share Debt & Revitalization Growth Projects Dividends Acquisitions Repurchase Repayment Projects Capital Structure Objectives Investment Criteria Cost Aligned with Strategic Pillars ► ► Stability 2 – 4 year simple payback period ► ► Flexibility > 20 – 50% ROIC ► ► Maximize shareholder value ► 19
  • 20. Case for improved valuation 3Yr Avg EBITDA/Sales2 3Yr Avg FCF Yield2 3Yr Avg EBITDA Growth2 20% 20% 18% 15% 7% 14% 14% 14% 13% 5% 10% 5% 4% 4% 4% 2% DOW PPG EMN ROH FMC CE -4% -7% DOW PPG EMN ROH FMC CE DOW PPG EMN ROH FMC CE NorthAvgEBITDAYield2 1 21 America Sales1 3Yr3YrForward % of Sales 3YrAvg % FCF Growth Asia EBITDA/Sales Avg of P/E2 66% 28% 12% 7% 20% 10% 15.8 20% 53% 52% 8% 18% 13.9 13.4 20% 45% 5% 45% 5% 15% 11.6 11.4 11.3 14% 14% 4% 4% 3% 15% 4% 14% 12% 28% 9% -4% -6% North America % of Sales1 Asia % of Sales1 DOW PPG EMN ROH FMC CE 59% 28% 57% 25% 49% 22% 38% 37% 16% 29% 13% 11% DOW PPG EMN ROH FMC CE DOW PPG EMN ROH FMC CE 1Based on information provided in 2007 Form 10-K filings 2Thompson Financial as of April 30, 2008, Company reports, Celanese estimates 20
  • 22. Delays continue to be common for acetyl projects Company Capacity 2005 2006 2007 2008 2009 2010 300kt BP/FPC SU A X 150kt BP / Yaraco A X SU 200kt Wujing A X X SU 150kt Sopo A X SU 150kt Fanavaran A X SU 200kt Lunan Cathay X SU A 500kt Cancelled Acetex (Tasnee) A 600kt Celanese Nanjing (Phase 1) X SU A X 550kt BP / Sinopec A X X X 425kt Sipchem A X X X 200kt Daqing A X SU 200kt Hualu Hensheng X A 350kt Lunan Cathay (expansion) A X 600kt Sopo (expansion) A X 200kt Tianjin Bohei A X Company announced startup CE 2005 update CE 2006 update CE 2007 update A X = Project delay SU = Actual plant startup 22
  • 23. 2008 business outlook (updated on April 22, 2008) Volume growth >2x GDP across both transportation ► and non-transportation applications Advanced ► Continued high energy and raw material costs Engineered expected to pressure margins 2008 Guidance: Materials ► Significant progress expected in Nanjing production capabilities Adjusted EPS $3.60 to $3.85 Synergy capture from APL integration ► Consumer ► Strong underlying business fundamentals Specialties Operating EBITDA High raw material costs continue ► Industrial $1,355 to $1,415 million ► Realize benefits from revitalization efforts Specialties Forecasted 2008 Continued strong global demand ► adjusted tax rate of ► Incremental acetic acid volume 26% associated with China expansion Acetyl ► VAM and acetic anhydride production scheduled to Intermediates begin in Nanjing ► Prices expected to adjust only modestly in 2008 23
  • 24. Advanced Engineered Materials in millions 1st Qtr 2008 1st Qtr 2007 Net Sales $262 $294 up 12% Operating EBITDA $67 $60 down 10% First Quarter 2008: ► Net sales increase driven by volume growth (6%) and positive currency effects (8%) ► Growth in China continues to drive results ► Slight pricing declines due to geographic and product mix ► Higher raw material and energy costs continue to pressure margins ► Overall lower earnings from equity affiliates contributed to decrease in Operating EBITDA 24
  • 25. Consumer Specialties in millions 1st Qtr 2008 1st Qtr 2007 Net Sales $269 $282 up 5% Operating EBITDA $60 $65 up 8% First Quarter 2008: ► Net sales increase primarily driven by European acquisition, improved pricing on global demand and favorable currency impacts ► Pricing more than offset significantly higher energy costs ► Operating EBITDA improvement also includes acquisition synergies 25
  • 26. Industrial Specialties in millions 1st Qtr 2008 1st Qtr 2007 Net Sales $346 $365 up 5% Operating EBITDA $26 $36 up 38% First Quarter 2008: ► Increase in net sales primarily driven by favorable pricing and foreign currency effects ► Volumes pressured by continued softness in U.S. housing and construction segments ► Increased revenues offset raw material cost pressures 26
  • 27. Acetyl Intermediates 1st Qtr 2008 1st Qtr 2007 in millions Net Sales $839 $1,096 up 31% Operating EBITDA $174 $246 up 41% First Quarter 2008: ► Strong global demand sustained higher pricing levels and drove record sales for the quarter ► Incremental volumes from the Nanjing plant also contributed to increase ► Favorable supply/demand environment and increased dividends from Ibn Sina more than offset higher raw material and energy costs 27
  • 28. Reg G: Reconciliation of Adjusted EPS Adjusted Earnings Per Share - Reconciliation of a Non-U.S. GAAP Measure Three Months Ended March 31, 2008 2007 (in $ millions, except per share data) Earnings from continuing operations 171 before tax and minority interests 218 Non-GAAP Adjustments: 1 Other charges and other adjustments 18 22 (2) Refinancing costs - Adjusted earnings from continuing operations 187 before tax and minority interests 240 2 Income tax provision on adjusted earnings (52) (62) - Minority interests - Adjusted earnings from continuing operations 178 135 Preferred dividends (2) (3) Adjusted net earnings available to common shareholders 175 133 Add back: Preferred dividends 2 3 Adjusted net earnings for adjusted EPS 178 135 Diluted shares (millions) Weighted average shares outstanding 159.3 152.0 Assumed conversion of Preferred Shares 12.0 12.0 Assumed conversion of Restricted Stock - 0.5 3.1 Assumed conversion of stock options 2.8 Total diluted shares 174.4 167.3 Adjusted EPS $ 1.06 $ 0.77 1 See Table 7 for details 2 The adjusted tax rate for the three months ended March 31, 2008 is 26% based on the forecasted adjusted tax rate for 2008. 28
  • 29. Reg G: Other Charges and Other Adjustments Other Charges and Other Adjustments Other Charges: Three Months Ended March 31, (in $ millions) 2008 2007 Employee termination benefits - 7 Plant/office closures - 7 Ticona Kelsterbach plant relocation - 2 1 Other - Total 16 1 Other Adjustments: 1 Three Months Ended Income March 31, Statement Classification (in $ millions) 2008 2007 Ethylene pipeline exit costs 10 Other income/expense, net - Business optimization 2 SG&A 9 Ticona Kelsterbach plant relocation - Cost of Sales (2) Other 5 Various (1) 6 17 Total 22 18 Total other charges and other adjustments 1 These items are included in net earnings but not included in other charges. 29
  • 30. Reg G: Other Charges and Other Adjustments Other Charges and Other Adjustments Other Charges: Three Months Ended Twelve Months Ended December 31, December 31, (in $ millions) 2007 2006 2007 2006 Employee termination benefits 1 12 5 32 (1) Plant/office closures (1) 11 7 Insurance recoveries associated with plumbing cases (2) (5) (2) (4) Insurance recoveries associated with Clear Lake, Texas - - (40) (40) Resolution of commercial disputes with a vendor - - (31) (31) Deferred compensation triggered by Exit Event - - - 74 Asset impairments - - - 9 Ticona Kelsterbach plant relocation - - 1 5 - Other 4 - 2 Total (60) (2) 58 10 Other Adjustments: 1 Three Months Ended Twelve Months Ended December 31, December 31, (in $ millions) 2007 2006 2007 2006 Executive severance & other costs related to Squeeze-Out 2 30 - - Ethylene pipeline exit costs - - - 10 Business optimization 8 12 8 18 Foreign exchange loss related to refinancing transaction - - - 22 Loss on AT Plastics films sale - - - 7 2 Discontinued methanol production 16 52 - 31 Gain on disposal of investment (Pemeas) (11) (11) - - Gain on Edmonton sale - - (34) (34) Other 2 (1) (7) 1 (33) 17 55 82 Total (93) 15 113 92 Total other charges and other adjustments 1 These items are included in net earnings but not included in other charges. 2 Adjusted earnings per share included earnings from its discontinued methanol production which was included in the company's 2007 guidance. 30
  • 31. 31 Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA - a Non-U.S. GAAP Measure Three Months Ended March 31, (in $ millions) 2008 2007 Net Sales 294 Advanced Engineered Materials 262 282 Consumer Specialties 269 365 Industrial Specialties 346 EBITDA 1,096 Acetyl Intermediates 839 1 Other Activities - 1 (191) Intersegment eliminations (162) Total 1,846 1,555 Operating Profit (Loss) 30 Advanced Engineered Materials 36 50 Consumer Specialties 48 17 Industrial Specialties 12 177 Acetyl Intermediates 132 1 Other Activities (40) (22) Total 234 206 Equity Earnings and Other Income/(Expense) 2 9 Advanced Engineered Materials 14 - Consumer Specialties - - Industrial Specialties - 29 Acetyl Intermediates 5 1 Other Activities 4 4 Total 42 23 Other Charges and Other Adjustments 3 1 Advanced Engineered Materials - 1 Consumer Specialties 1 5 Industrial Specialties - 8 Acetyl Intermediates 13 1 Other Activities 7 4 Total 22 18 Depreciation and Amortization Expense Reg G: Reconciliation of Operating 20 Advanced Engineered Materials 17 14 Consumer Specialties 11 14 Industrial Specialties 14 32 Acetyl Intermediates 24 1 Other Activities 2 3 Total 83 68 Operating EBITDA 60 Advanced Engineered Materials 67 65 Consumer Specialties 60 36 Industrial Specialties 26 246 Acetyl Intermediates 174 1 Other Activities (26) (12) Total 381 315 1 Other Activities primarily includes corporate selling, general and administrative expenses and the results from captive insurance companies. 2 Includes equity earnings from affiliates, dividends from cost investments and other income/(expense). 3 Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations (See Table 7).
  • 32. 32 Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA - a Non-U.S. GAAP Measure Three Months Ended Twelve Months Ended December 31, December 31, (in $ millions) 2007 2006 2007 2006 Net Sales 253 1,030 Advanced Engineered Materials 224 915 279 1,111 Consumer Specialties 224 876 EBITDA 331 1,346 Industrial Specialties 309 1,281 1,083 3,615 Acetyl Intermediates 831 3,351 1 Other Activities - 2 6 22 (186) (660) Intersegment eliminations (164) (667) Total 1,760 1,430 6,444 5,778 Operating Profit (Loss) 30 133 Advanced Engineered Materials 29 145 69 199 Consumer Specialties 41 165 26 28 Industrial Specialties 9 44 276 616 Acetyl Intermediates 107 456 1 Other Activities (77) (228) (46) (190) Total 324 140 748 620 Equity Earnings and Other Income/(Expense) 2 7 55 Advanced Engineered Materials 13 55 3 40 Consumer Specialties 2 24 - - Industrial Specialties - (1) 27 78 Acetyl Intermediates 23 63 1 Other Activities 8 - 12 22 Total 45 50 173 163 Other Charges and Other Adjustments 3 (10) (5) Advanced Engineered Materials (1) (5) (27) (16) Consumer Specialties - - (1) 32 Industrial Specialties 2 16 (97) (38) Acetyl Intermediates 16 52 1 Other Activities 42 140 (2) 29 Total (93) 15 113 92 Depreciation and Amortization Expense 18 69 Advanced Engineered Materials 17 65 12 51 Consumer Specialties 10 39 Reg G: Reconciliation of Operating 16 59 Industrial Specialties 14 59 25 106 Acetyl Intermediates 23 101 1 Other Activities - 5 6 2 Total 73 64 291 269 Operating EBITDA 45 252 Advanced Engineered Materials 58 260 57 274 Consumer Specialties 53 228 41 119 Industrial Specialties 25 118 231 762 Acetyl Intermediates 169 672 1 Other Activities (25) (82) (36) (134) Total 349 269 1,325 1,144 1 Other Activities primarily includes corporate selling, general and administrative expenses and the results from captive insurance companies. The 2007 Operating Profit (Loss) and Other Charges and Other Adjustments amounts include deductible associated with insurance recovery. 2 Includes equity earnings from affiliates, dividends from cost investments and other income/(expense). 3 Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations (See Table 7).